Literature DB >> 22631598

Poststroke infections are an independent risk factor for poor functional outcome after three-months in thrombolysed stroke patients.

Andrea Rocco1, Geraldine Fam, Marek Sykora, Jennifer Diedler, Simon Nagel, Peter Ringleb.   

Abstract

BACKGROUND: Infections are common complications in patients with acute ischemic stroke; however, the pathophysiology of the stroke-induced immunodepression is still under debate. Although it has been shown that increased mortality and longer hospital stay are associated with the presence of poststroke infections, it remains unclear if early poststroke infections occurring in the first seven-days have an effect on the overall functional outcome. AIMS: Aim of our study was to identify the frequency of poststroke infections in thrombolysed stroke patients and to analyze their effect on the outcome after three-months.
METHODS: From 1998 to 2011, all patients in our institution undergoing thrombolysis for acute ischemic stroke were included into a prospective database. Baseline variables, clinical, radiographic, and laboratory data were collected prospectively. Outcome measures included symptomatic intracerebral hemorrhage per European-Australasian Acute Stroke Study II criteria, mortality, and modified Rankin Scale at three-months. Logistic regression models were used to identify independent predictors for poor outcome where appropriate.
RESULTS: One thousand sixteen patients were included; of them, 36·3% had an infection during the first week. Pneumonia (9·6%) and urinary tract infections (5·4%) were most frequent. Severity of stroke (P < 0·0001), infarct size (P < 0·0001), atrial fibrillation (P = 0·005), and cardio embolic cause of stroke (P < 0·0001) were associated with infections. Age (odds ratio 1·089, 95% confidence interval 1·064-1·115, P < 0·0001), severity of stroke (odds ratio 1·111, 95% confidence interval 1·073-1·149; P < 0·0001) history of diabetes (odds ratio 0·555. 95% confidence interval 0·357-0·864; P = 0·009), infarct size (odds ratio 4·256 95% confidence interval 2·697-6·745; P < 0·0001), infections (odds ratio 1·548, 95% confidence interval 1·008-2·376; P = 0·046), and symptomatic intracerebral hemorrhage were independent predictors for poor outcome after three-months.
CONCLUSIONS: In our cohort of thrombolysed stroke patients, poststroke infections were frequent in patients with severe cardio embolic stroke, a large infarct, and a longer hospital stay; those patients have a higher risk of infection and a poorer functional outcome after three-months. This risk increases after occurrence of symptomatic intracerebral hemorrhage. Prevention of infection with antibiotic therapy or other prophylactic treatment could potentially lead to a better functional outcome and further randomized studies on this aspect are needed.
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.

Entities:  

Keywords:  acute stroke; complications; hemorrhage; infections; outcome; thrombolysis

Mesh:

Substances:

Year:  2012        PMID: 22631598     DOI: 10.1111/j.1747-4949.2012.00822.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  9 in total

1.  Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke.

Authors:  Christine Römer; Odilo Engel; Katarzyna Winek; Sonja Hochmeister; Tian Zhang; Georg Royl; Juliane Klehmet; Ulrich Dirnagl; Christian Meisel; Andreas Meisel
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

2.  Infections present on admission compared with hospital-acquired infections in acute ischemic stroke patients.

Authors:  Amelia K Boehme; Andre D Kumar; Adrianne M Dorsey; James E Siegler; Monica S Aswani; Michael J Lyerly; Dominique J Monlezun; Alexander J George; Karen C Albright; Timothy M Beasley; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-08-15       Impact factor: 2.136

3.  Follow-up C-reactive protein level is more strongly associated with outcome in stroke patients than admission levels.

Authors:  Andrea Rocco; Peter A Ringleb; Ulrike Grittner; Christian H Nolte; Alice Schneider; Simon Nagel
Journal:  Neurol Sci       Date:  2015-07-25       Impact factor: 3.307

4.  Effect of Statins on the Risk of Poststroke Pneumonia: National Population-Based Cohort Study.

Authors:  Tae-Jin Song; Jinkwon Kim
Journal:  Infect Drug Resist       Date:  2020-08-06       Impact factor: 4.003

Review 5.  Immunological mechanisms in poststroke dementia.

Authors:  Kristian P Doyle; Marion S Buckwalter
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 5.710

6.  Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach.

Authors:  Susann Hetze; Odilo Engel; Christine Römer; Susanne Mueller; Ulrich Dirnagl; Christian Meisel; Andreas Meisel
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-30       Impact factor: 6.200

7.  Procalcitonin related to stroke-associated pneumonia and clinical outcomes of acute ischemic stroke after IV rt-PA treatment.

Authors:  Guomei Shi; Minghao Li; Rujuan Zhou; Xiaorong Wang; Wu Xu; Feng Yang; Shouru Xue
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 5.046

8.  Epidemiologic Features, Risk Factors, and Outcomes of Respiratory Infection in Patients with Acute Stroke.

Authors:  Lunlin Mao; Xiaobo Liu; Peng Zheng; Saiping Wu
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

9.  Post-stroke infection in acute ischemic stroke patients treated with mechanical thrombectomy does not affect long-term outcome.

Authors:  Klaudia Nowak; Justyna Derbisz; Jan Pęksa; Bartłomiej Łasocha; Paweł Brzegowy; Joanna Slowik; Paweł Wrona; Roman Pulyk; Tadeusz Popiela; Agnieszka Slowik
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-12-29       Impact factor: 1.426

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.